Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Amivantamab + TKI for Lung Cancer
Recruiting1 awardPhase 1 & 2
Aurora, Colorado
This trial uses drugs to treat lung cancer by blocking pathways that allow cancer to resist current drugs. This could help stop cancer cells from adapting and becoming resistant.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service